Segmentectomy Clinical Trial
— DRIVATSOfficial title:
Three-dimensional Computed Tomography Reconstruction for Operative Planning in VATS Segmentectomy
NCT number | NCT04004494 |
Other study ID # | RTS-008 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 1, 2019 |
Est. completion date | December 31, 2023 |
Verified date | May 2024 |
Source | Ruijin Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Anatomical variations of pulmonary vessel may cause serious problems during pulmonary segmentectomy. Three-dimensional (3D)computed tomography (CT) presents 3D images of pulmonary vessels and the tracheobronchial tree and may help operative planning. Retrospective studies have identified the importance of 3-dimensional CT in the field of pulmonary segmentectomy. And the aim of this study is to compare the usefulness of 3-dimensional CT with standard chest CT in preoperative planning of video-assisted segmentectomy.
Status | Completed |
Enrollment | 191 |
Est. completion date | December 31, 2023 |
Est. primary completion date | October 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Age older than 18 years; 2. Pulmonary nodules or ground glass opacification (GGO) found in chest CT examination, and conform with indications for segmentectomy: Peripheral nodule 0.8-2 cm with at least one of the following: i. Histology of adenocarcinoma in situ; ii. Nodule has =50% ground-glass appearance on CT; iii. Radiologic surveillance confirms a long doubling time (=400 days). Segmentectomy should achieve parenchymal resection margins =2 cm or = the size of the nodule. 3. Adequate cardiac function, respiratory function, liver function and renal function for anesthesia and VATS segmentectomy. 4. American Society of Anesthesiologists (ASA) score: Grade I-III. 5. Patients who can coordinate the treatment and research and sign the informed consent. Exclusion Criteria: 1. Patients with a significant medical condition which is thought unlikely to tolerate the surgery. For example, cardiac disease, significant liver and renal function disorder. 2. Patients with psychiatric disease who are expected lack of compliance with the protocol. 3. Patients have history of chest trauma or surgery on ipsilateral chest which may cause pleural adhesion. |
Country | Name | City | State |
---|---|---|---|
China | Union Hospital of Fujian medical university | Fujian | Fujian |
China | Guangdong General Hospital | Guangdong | Guangdong |
China | Ruijin Hospital, Shanghai JiaoTong University School of Medicine | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Ruijin Hospital | Guangdong Provincial People's Hospital, Union hospital of Fujian Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Total hospitalization expenditures | cost in hospital | postoperative in-hospital stay up to 30 days | |
Other | Anatomical variations | Rate of anatomical variation of segmental bronchus and pulmonary vessel in Chinese population | During surgery | |
Primary | operative time | the time of operation | During surgery | |
Secondary | blood loss | Amount of intraoperative blood loss | During surgery | |
Secondary | conversion rate | the rate of conversion to open surgery in the operation | During surgery | |
Secondary | operative accident event | the accident event happened in operative. For example, a segmentectomy is converted to a lobectomy | During surgery | |
Secondary | Incidence of postoperative complications | mainly include: pneumonia, arrhythmia, incision infection, vocal cord paralysis, trachea cannula | Postoperative in-hospital stay up to 30 days | |
Secondary | Postoperative hospital stay | length of stay in hospitalization | Up to 24 weeks | |
Secondary | Duration of chest tube placement | Duration of chest tube placement | Up to 4 weeks | |
Secondary | 30-day mortality | 30-day mortality after surgery | Postoperative in-hospital stay up to 30 days | |
Secondary | dissection of lymph nodes | including overall lymph node count, number of stations dissected and number of lymph nodes in each lymph node station | 2 weeks after surgery | |
Secondary | Overall survival (OS) | Up to the date of death of any causes since the date of randomization | up to 60 months | |
Secondary | Disease-free survival (DFS) | Up to the date of disease recurrence since the date of randomization | up to 60 months | |
Secondary | Preoperative lung function | forced expiratory volume at one second(FEV1) in litre, maximal voluntary ventilation (MVV) in litre | Baseline | |
Secondary | Postoperative lung function | forced expiratory volume at one second(FEV1) in litre, maximal voluntary ventilation (MVV) in litre | at the 3rd month after surgery | |
Secondary | Incidence of change of surgical plan | Surgical plan is made based of the image of standard chest computed tomography or three-dimensional computed tomography, the targeted segmental bronchus and pulmonary vessels are decided preoperatively. Change of surgical plan is recorded when the actually resected bronchus and vessels are different to those in the preoperative surgical plan | During surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04842578 -
The Guidance of Thin Cross- Section of CT in Anatomic Segmentectomy
|
N/A | |
Not yet recruiting |
NCT05525923 -
OpalGenix (TS) - Personalized Postoperative Pain Management Following Thoracic Surgery in Adults
|
||
Recruiting |
NCT03227380 -
Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy
|
N/A | |
Active, not recruiting |
NCT02816671 -
MicroCutter Assisted Thoracic Surgery Hemostasis Registry
|
||
Terminated |
NCT03192904 -
Comparison of Energy Instruments and Stapling Device to Dissect Intersegmental Plane in Segmentectomy
|
N/A | |
Completed |
NCT01775657 -
Digital Versus Analog Pleural Drainage Following Pulmonary Resection
|
N/A | |
Recruiting |
NCT05717803 -
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
|
Phase 3 | |
Completed |
NCT05350137 -
Application of Carbon Dioxide for Identifying the Intersegmental Plane in Thoracoscopic Segmentectomy
|
N/A | |
Completed |
NCT06132607 -
3D Lung Reconstructions Using Open-source Software for Lung Cancer Surgery
|
N/A | |
Recruiting |
NCT05453721 -
Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane(IMPLANE-0529)
|
N/A |